Results 41 to 50 of about 1,781 (206)

Successful treatment of a patent urachus concurrent with pyocele in a newborn

Medicine, 2022
. Rationale:. A patent urachus is a rare congenital anomaly that atypically presents as an umbilical cord cyst or large umbilical cord. Here we describe a case of a giant umbilical cord cyst in a newborn diagnosed as a patent urachus.
Susie Kang, MD, Erika Imura, MD, Yoo-Jin Kim, MD, Shin Ae Yoon, MD, PhD, Ji Hyuk Lee, MD, PhD, Jin-Woo Park, MD, PhD, Maya Saranathan.   +6 more
doaj   +1 more source

Urachal adenocarcinoma masquerading as an urachal cyst [PDF]

Indian Journal of Surgery, 2008
Urachal adenocarcinoma arising in the dome of the bladder or at the pre-existing urachal remnant is rare. An early case of urachal cyst harboring adenocarcinoma, clinically diagnosed as ovarian tumor, which was surgically removed with a good prognosis is reported.
Dilip Kumar, Pal, Manoj Kumar, Chowdhury
openaire   +2 more sources

An infected urachal cyst [PDF]

BMJ Case Reports, 2013
Urachal cysts present very uncommonly in adults. We describe a 25-year-old man who attended with a discharging umbilical swelling and pain. Ultrasonography and CT scan demonstrated an infected urachal cyst which, following cystoscopy, was excised without complication.
Bhavna L, Gami, S, Biswas
openaire   +2 more sources

FROM DIAGNOSIS TO RECOVERY: A CASE REPORT OF AN INFECTED URACHAL CYST IN AN ELDERLY MALE

Jurnal Urologi Indonesia
Objective: This case report was aimed to present an infected urachal cysts in an elderly male. Case(s) Presentation: We are presenting a case of an infected urachal cyst actively draining pus through the umbilicus in a 72-year-old male.
Kavita Jadhav, Gadi Venkatesh, Rukmini Waghmare, Shubham Akotkar, Fahd Ahmad, Yashashri Waghmare   +5 more
doaj   +1 more source

To excise or not to excise infected urachal cysts: A case report and review of the literature

Journal of Pediatric Surgery Case Reports, 2017
Urachal anomalies, and urachal cysts in particular, are common congenital anomalies that can remain asymptomatic throughout a lifetime or rarely cause life threatening illness if infected.
Shadwa Hassan, DO, June Koshy, MD, Richard Sidlow, MD, Hadassa Leader, MD, Mark Horowitz, MD   +4 more
doaj   +1 more source

Prenatally Ruptured Patent Urachus: A Case Report and Review of Literature

Medicina, 2022
Patent urachus is a type of urachal anomaly in which the urachus does not tail off but remains connected to the bladder in the umbilicus. The prevalence of patent urachus is very low.
Ji-Young Kwon, Seung-Yeon Pyeon
doaj   +1 more source

Laparoscopic stapled partial cystectomy with intraoperative cystourethroscopy for urothelial carcinoma in two dogs

Veterinary Surgery, EarlyView.
Abstract Objective To describe the procedure and short‐term outcomes of two dogs that underwent laparoscopic stapled partial cystectomy with intraoperative cystoscopy for excision of solitary, non‐trigonal, urothelial carcinoma lesions. Animals A 12‐year‐old female spayed mixed breed and a 13‐year‐old female spayed Siberian Husky.
Maureen A. Griffin, Christian Folk, Nicole J. Buote   +2 more
wiley   +1 more source

Infected Urachal Cyst in an Adult: A Laparoscopic Approach

Case Reports in Gastroenterology, 2016
Urachal cysts occur infrequently in adults and are rarely reported in the literature. Laparoscopic excision or robot-assisted laparoscopic excision of urachal cysts has widely been applied in recent years.
Ching-Ming Kwok
doaj   +1 more source

The role of laparoscopy in the management of urachal anomalies in children [PDF]

, 2018
Objectives Management for urachal anomalies (UAs) is controversial. Although traditional treatment of UAs has been surgical excision, recent literature report also a conservative approach.
Appignani, Antonino, Bertozzi, Mirko, Nardi, Niccolo, Riccioni, Sara   +3 more
core   +2 more sources

Olaparib for patients with tumors harboring alterations in homologous recombination repair genes: Results from the drug rediscovery protocol

International Journal of Cancer, Volume 158, Issue 6, Page 1617-1627, 15 March 2026.
What's new? PARP inhibitors are effective in patients with inactivating alterations in the BRCA1/2 genes across tumor types. However, the efficacy of PARP inhibitors in patients with other inactivated homologous recombination repair genes remains unclear. This knowledge gap and discrepancies in EMA/FDA approvals highlight the need for better biomarkers.
Ilse A. C. Spiekman, Niven Mehra, Laurien J. Zeverijn, Birgit S. Geurts, Karlijn Verkerk, Soemeya F. Haj Mohammad, Vincent van der Noort, Paul Roepman, Wendy W. J. de Leng, Anne M. L. Jansen, Addy C. M. van de Luijtgaarden, Theo van Voorthuizen, Tineke E. Buffart, Hans Gelderblom, Emile E. Voest, Henk M. W. Verheul   +15 more
wiley   +1 more source